A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe alopecia areata.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/phase-2b-findings-support-novel-agent-treat-alopecia-areata-2026a1000aap?src=rss
Author :
Publish date : 2026-04-03 20:15:00
Copyright for syndicated content belongs to the linked Source.
